Digital Evolution: Novo Nordisk's Shift to Ontology-Based Data Management
Abstract
Biomedical data is growing exponentially, and managing it is increasingly challenging. While Findable, Accessible, Interoperable and Reusable (FAIR) data principles provide guidance, their adoption has proven difficult, especially in larger enterprises like pharmaceutical companies. In this manuscript, we describe how we leverage an Ontology-Based Data Management (OBDM) strategy for digital transformation in Novo Nordisk Research & Early Development. Here, we include both our technical blueprint and our approach for organizational change management. We further discuss how such an OBDM ecosystem plays a pivotal role in the organizations digital aspirations for data federation and discovery fuelled by artificial intelligence. Our aim for this paper is to share the lessons learned in order to foster dialogue with parties navigating similar waters while collectively advancing the efforts in the fields of data management, semantics and data driven drug discovery.
Keywords
Cite
@article{arxiv.2405.05413,
title = {Digital Evolution: Novo Nordisk's Shift to Ontology-Based Data Management},
author = {Shawn Zheng Kai Tan and Shounak Baksi and Thomas Gade Bjerregaard and Preethi Elangovan and Thrishna Kuttikattu Gopalakrishnan and Darko Hric and Joffrey Joumaa and Beidi Li and Kashif Rabbani and Santhosh Kannan Venkatesan and Joshua Daniel Valdez and Saritha Vettikunnel Kuriakose},
journal= {arXiv preprint arXiv:2405.05413},
year = {2024}
}
Comments
14 pages, 2 figures